The Trump administration is dropping a plan to curb billions of dollars in annual rebates that drugmakers give middlemen in Medicare, a proposal it had said would drive down the prices consumers pay for prescription drugs.
The Trump administration is dropping a plan to curb billions of dollars in annual rebates that drugmakers give middlemen in Medicare, a proposal it had said would drive down the prices consumers pay for prescription drugs.